Karl-Werner Schweppe

ORCID: 0000-0003-2617-4650 · 92 papers in corpus
1989
·doi:10.1515/9783110869590-011
nonrandomized-trial 1989
Archives of gynecology and obstetrics ·doi:10.1007/bf00934075

To investigate the effects of the LH-RH agonist Buserelin [D-Ser (But)6 des-Gly10-LHRH ethylamide] on endometriosis, 64 patients were treated with 900 micrograms/d Buserelin intranasally over 6 months after histological verification of the …

review 1989
Der Gynäkologe
other 1988
Der Gynäkologe
nonrandomized-trial 1988
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1026554

Over a six-month period, 62 endometriosis patients were given 600 mg per day of the ethisterone derivative danazol. Blood count and coagulation status were checked before and during treatment. There was a significant increase (p less than 0…

other 1987
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1035798

Between 1983 and 1986 40 patients were treated for external genital endometriosis with the LHRH agonist buserelin. Ovarian suppression was achieved for a period of six months with a dose of 900 to 1,800 mcg per day. In addition to gynecolog…

1987
·doi:10.1159/000414863
nonrandomized-trial 1986
Progress in clinical and biological research
review 1986
Progress in clinical and biological research
1985
·doi:10.1016/s0015-0282(16)48794-7
nonrandomized-trial 1984
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme ·doi:10.1055/s-2007-1014859

Previous data of lipid and lipoprotein level changes with the application of danazol, an isoxazol derivative of 17-alpha-ethinyl testosterone, have been conflicting. We measured cholesterol, triglycerides, low density lipoproteins and high …

nonrandomized-trial 1984
·doi:10.1097/00006254-198411000-00018

Laparoscopy permits identification of endometriotic foci, but the evaluation is not closely correlated with the histological and ultrastructural findings, which include a wide spectrum of variations. Endometriotic implants have been studied…

nonrandomized-trial 1984
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/0028-2243(84)90143-6

The comparison of the ultrastructural features of endometriotic implants in 96 patients before and after suppressive therapy by danazol showed that the glands of the ectopic endometrium had a wide range of morphologic development. In about …

other 1984
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(84)90546-5

Ultrastructural features of endometriotic implants suggest an incomplete response to the prevalent hormonal milieu. The cyclic changes, especially in the secretory phase, appear to depend more on the morphologic differentiation of the ectop…

other 1981
Fertility and sterility ·doi:10.1016/s0015-0282(16)45915-7

Patients (n = 10) with endometriosis or fibrocystic mammary disease were treated with an oral dose of 4 x 200 mg danazol for 6 months. Prolactin and gonadotropin secretion was evaluated before, and in some of them during 1, 3, and 6 months …

other 1981
Obstetrics & Gynecology

This report, the first ultrastructural study of endometriotic implants, compares the ectopic endometrium in 14 patients with that found in the uterus. The ultrastructural features of most of the glands of the ectopic endometrium resemble th…

other 1981
Fertility and sterility ·doi:10.1016/s0015-0282(16)45612-8

Electron microscopic examinations were carried out on 29 representative endometriotic glands obtained from 16 biopsies. Patients with endometriosis diagnosed by laparoscopy and confirmed by laparoscopic biopsy prior to hormonal treatment re…